FDA Inspection 1182096 - Boehringer Ingelheim RCV GmbH & Co KG - September 16, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Boehringer Ingelheim RCV GmbH & Co KG, with an inspection on September 16, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Boehringer Ingelheim RCV GmbH & Co KG
Inspection Date: September 16, 2022
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 39d7534c-cf3e-4996-a6fd-8da44ba47824